Current burden, incidence trends, and future projections of pancreatic cancer in adults worldwide

Background: Adult pancreatic cancer has a high mortality burden and poor survival. This study aimed to assess the current burden, geographic and socioeconomic differences, past incidence trends, and future burden. Methods: Publicly available data were obtained from the Global Cancer Observatory 2022 (GLOBOCAN 2022), Cancer Incidence in Five Continents Plus (CI5plus), the Global Burden of Disease study (GBD), Human Development Reports, the United Nations M49 classification, and World Population Prospects 2024. Adults aged 20 years and older were included. GLOBOCAN 2022 was used to estimate the disease burden in 2022. National Human Development Index values were correlated with age-standardised incidence rate (ASIR) and age-standardised mortality rate (ASMR) using Spearman correlation analysis. CI5plus data from 2000 to 2017 were used to assess sex-specific incidence trends using estimated annual percentage change. GBD data and World Population Prospects 2024 were used to project future burden from 2024 to 2045 using a Bayesian age-period-cohort model. Results: In 2022, there were 510,529 new cases and 467,290 deaths from pancreatic cancer worldwide among adults. Eastern Asia recorded the largest numbers of new cases and deaths. Western Europe had the highest ASIR and ASMR, while South Central Asia had the lowest. Countries with a very high Human Development Index (HDI) had the greatest burden, whereas those with a low HDI had the lowest. Adults aged 60-74 years accounted for the largest numbers of new cases and deaths. National Human Development Index was associated with ASIR and ASMR. Incidence trends from 2000 to 2017 varied across cancer registries and by sex. Projections showed increasing new cases and deaths from 2024 to 2045. Conclusions: Adult pancreatic cancer remains a major global health burden. The burden is projected to continue increasing. These findings may be useful for adult pancreatic cancer prevention in different regions.

Authors

Institutions

Publication Details

Journal
Journal of Global Health
Published
2026-08-28
DOI
https://doi.org/10.7189/jogh.16.04278
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Current burden, incidence trends, and future projections of pancreatic cancer in adults worldwide

Haiyan Guo, Qin Zhao, Yong Ling, Enhui Zhang et al.
Journal of Global Health
Pancreatic and Hepatic Oncology Research
article

Current burden, incidence trends, and future projections of pancreatic cancer in adults worldwide

Haiyan Guo, Qin Zhao, Yong Ling, Enhui Zhang, Shaona Li
article en

Abstract

Background: Adult pancreatic cancer has a high mortality burden and poor survival. This study aimed to assess the current burden, geographic and socioeconomic differences, past incidence trends, and future burden. Methods: Publicly available data were obtained from the Global Cancer Observatory 2022 (GLOBOCAN 2022), Cancer Incidence in Five Continents Plus (CI5plus), the Global Burden of Disease study (GBD), Human Development Reports, the United Nations M49 classification, and World Population Prospects 2024. Adults aged 20 years and older were included. GLOBOCAN 2022 was used to estimate the disease burden in 2022. National Human Development Index values were correlated with age-standardised incidence rate (ASIR) and age-standardised mortality rate (ASMR) using Spearman correlation analysis. CI5plus data from 2000 to 2017 were used to assess sex-specific incidence trends using estimated annual percentage change. GBD data and World Population Prospects 2024 were used to project future burden from 2024 to 2045 using a Bayesian age-period-cohort model. Results: In 2022, there were 510,529 new cases and 467,290 deaths from pancreatic cancer worldwide among adults. Eastern Asia recorded the largest numbers of new cases and deaths. Western Europe had the highest ASIR and ASMR, while South Central Asia had the lowest. Countries with a very high Human Development Index (HDI) had the greatest burden, whereas those with a low HDI had the lowest. Adults aged 60-74 years accounted for the largest numbers of new cases and deaths. National Human Development Index was associated with ASIR and ASMR. Incidence trends from 2000 to 2017 varied across cancer registries and by sex. Projections showed increasing new cases and deaths from 2024 to 2045. Conclusions: Adult pancreatic cancer remains a major global health burden. The burden is projected to continue increasing. These findings may be useful for adult pancreatic cancer prevention in different regions.

Journal of Global HealthVol. 16
Qingdao University (CN), Affiliated Hospital of Qingdao University (CN)
Openalex Percentile: Top 13%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.